Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer
暂无分享,去创建一个
Michael J Kerin | Nicola Miller | H. Heneghan | N. Miller | M. Kerin | J. Newell | K. Sweeney | A. Lowery | John Newell | Helen M Heneghan | Aoife J Lowery | Karl J Sweeney
[1] R. Stephens,et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. , 2006, Cancer cell.
[2] C. Klinge,et al. Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells , 2009, Nucleic acids research.
[3] J. Elmore,et al. Background Methods Results , 2009 .
[4] F. Slack,et al. The let-7 family of microRNAs. , 2008, Trends in cell biology.
[5] Michael J Kerin,et al. MicroRNAs as Prognostic Indicators and Therapeutic Targets: Potential Effect on Breast Cancer Management , 2008, Clinical Cancer Research.
[6] Yariv Yogev,et al. Serum MicroRNAs Are Promising Novel Biomarkers , 2008, PloS one.
[7] C. Croce,et al. MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.
[8] F. Slack,et al. A truth serum for cancer — microRNAs have major potential as cancer biomarkers , 2008, Cell Research.
[9] A. Harris,et al. Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma , 2008, British journal of haematology.
[10] Hansjuerg Alder,et al. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. , 2009, Gynecologic oncology.
[11] L. Hood,et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury , 2009, Proceedings of the National Academy of Sciences.
[12] X. Chen,et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.
[13] N. Miller,et al. Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer , 2008, BMC Molecular Biology.
[14] B. Qian,et al. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-β1 , 2009, Breast Cancer Research and Treatment.
[15] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[16] A. Howell,et al. Evaluation of the current knowledge limitations in breast cancer research: a gap analysis , 2008, Breast Cancer Research.
[17] G. Lutz,et al. Nanopolymers improve delivery of exon skipping oligonucleotides and concomitant dystrophin expression in skeletal muscle of mdx mice , 2008, BMC biotechnology.
[18] T. Kinoshita,et al. Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in breast cancer , 2008, International Journal of Clinical Oncology.
[19] M. Kerin,et al. An evaluation of preoperative CA 15-3 measurement in primary breast carcinoma. , 1995, British Journal of Cancer.
[20] M. Dowsett,et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. , 2005, The New England journal of medicine.
[21] R. Cress,et al. Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype , 2007, Cancer.
[22] Qiong Shao,et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. , 2008, RNA.
[23] H. Sültmann,et al. The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. , 2007, Cancer research.
[24] Robert A. Weinberg,et al. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer (Nature (2007) 449, (682-688)) , 2008 .
[25] R. Bast,et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] C. Benz,et al. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies , 2006, Molecular Cancer.
[27] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.